BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009-3020. [PMID: 15265787 DOI: 10.1182/blood-2004-02-0405] [Cited by in Crossref: 340] [Cited by in F6Publishing: 285] [Article Influence: 18.9] [Reference Citation Analysis]
Number Citing Articles
1 Verma R, Dhamija R, Leeburg WT, Rafi M, Loehrke ME. Burkitt Lymphoma Presenting as Ptosis in a Man With Human Immunodeficiency Virus. The American Journal of the Medical Sciences 2011;342:427-8. [DOI: 10.1097/maj.0b013e31822978fc] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Johnson MJ, Laoharawee K, Lahr WS, Webber BR, Moriarity BS. Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease. Sci Rep 2018;8:12144. [PMID: 30108345 DOI: 10.1038/s41598-018-30358-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
3 Chuang S, Huang W, Hsieh P, Jung Y, Ye H, Du M, Lu C, Cho C, Hsiao S, Hsu Y, Lin K. Sporadic paediatric and adult Burkitt lymphomas share similar phenotypic and genotypic features. Histopathology 2008;52:427-35. [DOI: 10.1111/j.1365-2559.2008.02974.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
4 Della Rocca AM, Leonart LP, Ferreira VL, Tonin FS, Steffenello-Durigon G, Del Moral JAG, Fernandez-Llimos F, Pontarolo R. Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies. Clin Lymphoma Myeloma Leuk 2021;21:514-25. [PMID: 33947633 DOI: 10.1016/j.clml.2021.03.012] [Reference Citation Analysis]
5 Baig I, Webb A, Crowell EL, Supsupin EP, Adesina OO. Burkitt lymphoma masquerading as Tolosa-Hunt syndrome in an HIV-seropositive patient. Eur J Ophthalmol 2020;30:NP41-6. [PMID: 31018683 DOI: 10.1177/1120672119842998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ghazzaui N, Issaoui H, Ferrad M, Carrion C, Cook-Moreau J, Denizot Y, Boyer F. Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas. Blood Adv 2020;4:28-39. [PMID: 31899800 DOI: 10.1182/bloodadvances.2019000845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Soyland DJ, Thanel PF, Sievers ME, Wagner K, Vuong SM. Primary epidural sporadic Burkitt lymphoma in a 3-year-old: Case report and literature review. Surgical Neurology International 2022;13:106. [DOI: 10.25259/sni_1172_2021] [Reference Citation Analysis]
8 Albano D, Bosio G, Re A, Pagani C, Giubbini R, Bertagna F. Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET/CT in adult Burkitt's lymphoma: the role of Deauville and IHP criteria. Leuk Lymphoma 2019;60:326-33. [PMID: 29966473 DOI: 10.1080/10428194.2018.1482541] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay E, Sanger WG, Talley P, Perkins SL, Raphaël M, McCarthy K, Sposto R, Gerrard M, Bernheim A, Patte C; FAB/LMB 96 International Study Committee. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Leukemia 2009;23:323-31. [PMID: 19020548 DOI: 10.1038/leu.2008.312] [Cited by in Crossref: 96] [Cited by in F6Publishing: 72] [Article Influence: 6.9] [Reference Citation Analysis]
10 Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C, Deffenbacher K, Lachel CM, Wang C, Rohr J, Guo S, Smith LM, Wright G, Bhagavathi S, Dybkaer K, Fu K, Greiner TC, Vose JM, Jaffe E, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Armitage JO, Weisenburger DD, Staudt LM, Gascoyne RD, McKeithan TW, Chan WC. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood 2015;125:1137-45. [PMID: 25498913 DOI: 10.1182/blood-2014-04-566778] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 8.9] [Reference Citation Analysis]
11 Ahmed SO, Sureda A, Aljurf M. The role of hematopoietic SCT in adult Burkitt lymphoma. Bone Marrow Transplant 2013;48:617-29. [PMID: 22858508 DOI: 10.1038/bmt.2012.129] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 Malathi L, Amsaveni R, Anitha N, Balachander N. Reticuloendothelial malignancy of head and neck: A comprehensive review. J Pharm Bioallied Sci 2015;7:S145-57. [PMID: 26015695 DOI: 10.4103/0975-7406.155867] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Amin R, Marfak A, Pangault C, Oblet C, Chanut A, Tarte K, Denizot Y, Cogné M. The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model. Oncotarget 2014;5:8995-9006. [PMID: 25229630 DOI: 10.18632/oncotarget.2297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, Widemann B, Staudt LM, Jaffe ES, Little RF, Wilson WH. Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med 2013;369:1915-25. [PMID: 24224624 DOI: 10.1056/NEJMoa1308392] [Cited by in Crossref: 219] [Cited by in F6Publishing: 86] [Article Influence: 24.3] [Reference Citation Analysis]
15 Byrne AJ, Bright SA, McKeown JP, O'Brien JE, Twamley B, Fayne D, Williams DC, Meegan MJ. Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt's Lymphoma. Pharmaceuticals (Basel) 2020;13:E16. [PMID: 31963567 DOI: 10.3390/ph13010016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Quintanilla-Martinez L, de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y, Parrens M, Pileri S, Ott G. Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop 2009;2:211-36. [PMID: 20309430 DOI: 10.1007/s12308-009-0053-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
17 Ojha J, Gupta A, Aziz N. Intraoral diffuse large B-cell lymphoma with Burkitt-like morphology in an HIV-positive patient--a diagnostic dilemma. J Oral Maxillofac Surg 2010;68:2632-8. [PMID: 20591554 DOI: 10.1016/j.joms.2009.09.061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Liang Y, Ding L, Li X, Wang W, Zhang X. Oculomotor nerve palsy as a preceding symptom of adult sporadic Burkitt lymphoma: A case report and review of the literature. Oncol Lett 2017;13:1315-8. [PMID: 28454254 DOI: 10.3892/ol.2017.5583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Bellan C, Stefano L, Giulia de F, Rogena EA, Lorenzo L. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. Hematol Oncol 2010;28:53-6. [PMID: 19844983 DOI: 10.1002/hon.916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.2] [Reference Citation Analysis]
20 Maramattom LV, Hari PN, Burns LJ, Carreras J, Arcese W, Cairo MS, Costa LJ, Fenske TS, Lill M, Freytes CO, Gale RP, Gross TG, Hale GA, Hamadani M, Holmberg LA, Hsu JW, Inwards DJ, Lazarus HM, Marks DI, Maloney DG, Maziarz RT, Montoto S, Rizzieri DA, Wirk B, Gajewski JL. Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2013;19:173-9. [PMID: 23200705 DOI: 10.1016/j.bbmt.2012.11.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
21 Miller AR, Cipkala DA, Cain MP. Gross hematuria and focal renal masses as initial features of a mature B-cell leukemia in an adolescent male. Urology 2015;85:470-3. [PMID: 25559723 DOI: 10.1016/j.urology.2014.10.028] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Sun Y, Ottosson A, Pervaiz S, Fadeel B. Smac-mediated sensitization of human B-lymphoma cells to staurosporine- and lactacystin-triggered apoptosis is apoptosome-dependent. Leukemia 2007;21:1035-43. [DOI: 10.1038/sj.leu.2404660] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
23 Bianchi P, Torcia F, Vitali M, Cozza G, Matteoli M, Giovanale V. An atypical presentation of sporadic ovarian Burkitt's lymphoma: case report and review of the literature. J Ovarian Res 2013;6:46. [PMID: 23826666 DOI: 10.1186/1757-2215-6-46] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
24 Yang D, Wang P, Chen J, Li CX, Zhang Y, Chen XC, Wu DP. [Long term efficacy of COPADM regimen in the treatment of 20 patients with Burkitt lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2018;39:645-9. [PMID: 30180465 DOI: 10.3760/cma.j.issn.0253-2727.2018.08.007] [Reference Citation Analysis]
25 Bernardi S, Michelli A, Bonazza D, Calabrò V, Zanconati F, Pozzato G, Fabris B. Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature. BMC Endocr Disord 2018;18:86. [PMID: 30453922 DOI: 10.1186/s12902-018-0312-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Said J. Diffuse Aggressive B-cell Lymphomas. Advances in Anatomic Pathology 2009;16:216-35. [DOI: 10.1097/pap.0b013e3181a9d5d2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
27 Degeorges S, Mesnil A, Marion-Audibert AM, Bouafia-Sauvy F, Berger F, Bancel B, Barnoud R, Rode A, Péré-Vergé D, Souquet JC. [Ano-rectal symptoms, related to Epstein-Barr Virus-Associated Burkitt's lymphoma in an immunocompetent patient]. Gastroenterol Clin Biol 2007;31:442-4. [PMID: 17483786 DOI: 10.1016/s0399-8320(07)89408-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
28 Kojima Y, Hagiwara S, Uehira T, Ajisawa A, Kitanaka A, Tanuma J, Okada S, Nagai H. Clinical Outcomes of AIDS-related Burkitt Lymphoma: A Multi-institution Retrospective Survey in Japan. Japanese Journal of Clinical Oncology 2014;44:318-23. [DOI: 10.1093/jjco/hyu012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Sun J, Yu W, Zhang X. MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia. Ann Hematol 2020;99:185-8. [DOI: 10.1007/s00277-019-03857-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
30 Jaglowski SM, Linden E, Termuhlen AM, Flynn JM. Lymphoma in adolescents and young adults. Semin Oncol 2009;36:381-418. [PMID: 19835736 DOI: 10.1053/j.seminoncol.2009.07.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
31 Truffinet V, Pinaud E, Cogné N, Petit B, Guglielmi L, Cogné M, Denizot Y. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype. J Immunol 2007;179:6033-42. [PMID: 17947677 DOI: 10.4049/jimmunol.179.9.6033] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
32 Liu J, Dai X, Xu Y, Liu P, Zhang Y, Liu X, Fang Z, Lin D, Xiao R, Huang R, Huang H. Inhibition of Lymphoma Cell Proliferation by Peroxisomal Proliferator-Activated Receptor-γ Ligands via Wnt Signaling Pathway. Cell Biochem Biophys 2012;62:19-27. [DOI: 10.1007/s12013-011-9253-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
33 Cerny J, Devitt K, Yu H, Ramanathan M, Woda B, Nath R. Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation. Leuk Res Rep 2014;3:51-3. [PMID: 25068102 DOI: 10.1016/j.lrr.2014.06.002] [Reference Citation Analysis]
34 Maifrede S, Martin K, Podszywalow-Bartnicka P, Sullivan-Reed K, Langer SK, Nejati R, Dasgupta Y, Hulse M, Gritsyuk D, Nieborowska-Skorska M, Lupey-Green LN, Zhao H, Piwocka K, Wasik MA, Tempera I, Skorski T. IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors. Mol Cancer Res 2017;15:967-72. [PMID: 28634224 DOI: 10.1158/1541-7786.MCR-16-0468] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
35 Mascarenhas JG, Araújo Júnior F, Bolzan TV, Gregório LC, Kosugi EM. Nasopharyngeal Burkitt lymphoma as an early AIDS manifestation. Braz J Otorhinolaryngol 2014;80:546-8. [PMID: 25457076 DOI: 10.1016/j.bjorl.2014.05.030] [Reference Citation Analysis]
36 Nayak SR, Rao GB, Yerraguntla SS, Bodepudi S. Jejunal Perforation: A Rare Presentation of Burkitt's Lymphoma-Successful Management. Case Rep Oncol Med 2014;2014:538359. [PMID: 24995139 DOI: 10.1155/2014/538359] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Fiancette R, Rouaud P, Vincent-Fabert C, Laffleur B, Magnone V, Cogné M, Denizot Y. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene. J Immunol 2011;187:5772-82. [PMID: 22039300 DOI: 10.4049/jimmunol.1102059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
38 Polizzotto MN, Mccomish JS, Dawson MA, Opat SS, Cole-sinclair MF. Burkitt lymphoma in the setting of common variable immunodeficiency. Ann Hematol 2009;88:819-20. [DOI: 10.1007/s00277-008-0691-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Goto M, Onizawa K, Yanagawa T, Yamagata K, Shinozuka K, Nishikii H, Koganemaru H, Chiba S, Bukawa H. Human immunodeficiency virus-associated Burkitt's lymphoma in oral cavity of Japanese patient. J Oral Maxillofac Surg 2012;70:1885-90. [PMID: 22079069 DOI: 10.1016/j.joms.2011.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Gonin J, Larousserie F, Bastard C, Picquenot JM, Couturier J, Radford-Weiss I, Dietrich C, Brousse N, Vacher-Lavenu MC, Devergne O. Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. PLoS One 2011;6:e24617. [PMID: 21931777 DOI: 10.1371/journal.pone.0024617] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
41 Hill QA, Owen RG. CNS prophylaxis in lymphoma: Who to target and what therapy to use. Blood Reviews 2006;20:319-32. [DOI: 10.1016/j.blre.2006.02.001] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 5.7] [Reference Citation Analysis]
42 Kimura N, Miyakawa Y, Kohmura K, Umezawa K, Ikeda Y, Kizaki M. Targeting NF-κB and induction of apoptosis by novel NF-κB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells. Leukemia Research 2007;31:1529-35. [DOI: 10.1016/j.leukres.2007.02.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
43 Castillo JJ, Winer ES, Olszewski AJ. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database. Cancer 2013;119:3672-9. [PMID: 23913575 DOI: 10.1002/cncr.28264] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
44 Syed N, Smith P, Sullivan A, Spender LC, Dyer M, Karran L, O'nions J, Allday M, Hoffmann I, Crawford D, Griffin B, Farrell PJ, Crook T. Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood 2005;107:250-6. [DOI: 10.1182/blood-2005-03-1194] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 5.1] [Reference Citation Analysis]
45 Kataoka K, Seo S, Sugawara Y, Ota S, Imai Y, Takahashi T, Fukayama M, Kokudo N, Kurokawa M. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature. Leukemia & Lymphoma 2010;51:1494-501. [DOI: 10.3109/10428194.2010.492063] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
46 Brown HE, Dennis LK, Lauro P, Jain P, Pelley E, Oren E. Emerging Evidence for Infectious Causes of Cancer in the United States. Epidemiol Rev 2019;41:82-96. [PMID: 32294189 DOI: 10.1093/epirev/mxz003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Gupta S, Aitken JF, Bartels U, Brierley J, Dolendo M, Friedrich P, Fuentes-alabi S, Garrido CP, Gatta G, Gospodarowicz M, Gross T, Howard SC, Molyneux E, Moreno F, Pole JD, Pritchard-jones K, Ramirez O, Ries LAG, Rodriguez-galindo C, Shin HY, Steliarova-foucher E, Sung L, Supriyadi E, Swaminathan R, Torode J, Vora T, Kutluk T, Frazier AL. Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. The Lancet Oncology 2016;17:e163-72. [DOI: 10.1016/s1470-2045(15)00539-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
48 Hanich T, Majnarić L, Janković D, Šabanović Š, Včev A. Nodular lymphoid hyperplasia complicated with ileal Burkitt's lymphoma in an adult patient with selective IgA deficiency. Int J Surg Case Rep 2017;30:69-72. [PMID: 27940199 DOI: 10.1016/j.ijscr.2016.11.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Snell PD, Das K. Gastroduodenal Burkitt Lymphoma Presenting as Demyelinating Polyneuropathy. Clin Gastroenterol Hepatol 2017;15:A23-4. [PMID: 28532696 DOI: 10.1016/j.cgh.2017.05.024] [Reference Citation Analysis]
50 Burchard P, Thomay AA. Resection of a colonic mass following trauma: a diagnostic dilemma. J Surg Case Rep 2020;2020:rjaa226. [PMID: 32728415 DOI: 10.1093/jscr/rjaa226] [Reference Citation Analysis]
51 Henrich S, Cordwell SJ, Crossett B, Baker MS, Christopherson RI. The nuclear proteome and DNA-binding fraction of human Raji lymphoma cells. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2007;1774:413-32. [DOI: 10.1016/j.bbapap.2006.12.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
52 Bacolla A, Wojciechowska M, Kosmider B, Larson JE, Wells RD. The involvement of non-B DNA structures in gross chromosomal rearrangements. DNA Repair (Amst) 2006;5:1161-70. [PMID: 16807140 DOI: 10.1016/j.dnarep.2006.05.032] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 3.9] [Reference Citation Analysis]
53 Albano D, Re A, Tucci A, Giubbini R, Bertagna F. Prognostic role of ΔMTV and ΔTLG in Burkitt lymphoma. Ann Nucl Med 2019;33:280-7. [PMID: 30788775 DOI: 10.1007/s12149-019-01338-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
54 Carvalho JR, Carrilho-Ribeiro L, Zagalo A, Medeiros FC, Ferreira C, Velosa J. A rare case of Burkitt's lymphoma of the duodenal bulb. Ann Gastroenterol 2016;29:230-2. [PMID: 27065741 DOI: 10.20524/aog.2016.0021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Möller P, Stilgenbauer S, Pollack JR, Wirth T. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008;112:4202-4212. [PMID: 18713946 DOI: 10.1182/blood-2008-03-147645] [Cited by in Crossref: 290] [Cited by in F6Publishing: 273] [Article Influence: 20.7] [Reference Citation Analysis]
56 Park YH, Kim WS, Kang HJ, Na II, Ryoo BY, Yang SH, Lee SS, Uhm JE, Kim K, Jung CW, Park K, Ko YH. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia. Ann Hematol 2006;85:285-90. [PMID: 16518604 DOI: 10.1007/s00277-005-0050-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
57 Sohani AR, Hasserjian RP. Diagnosis of Burkitt Lymphoma and Related High-Grade B-Cell Neoplasms. Surg Pathol Clin 2010;3:1035-59. [PMID: 26839298 DOI: 10.1016/j.path.2010.09.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Wei WX, Huang JJ, Li WY, Zhang X, Xia Y, Jiang WQ, Fan W, Li ZM. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma. Chin J Cancer 2015;34:608-13. [PMID: 26630874 DOI: 10.1186/s40880-015-0057-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
59 Kim KT, Baird K, Davis S, Piloto O, Levis M, Li L, Chen P, Meltzer P, Small D. Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells. Br J Haematol 2007;138:603-15. [PMID: 17686054 DOI: 10.1111/j.1365-2141.2007.06696.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
60 Schneider C, Setty M, Holmes AB, Maute RL, Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R, Basso K. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas. Proc Natl Acad Sci U S A 2014;111:8185-90. [PMID: 24843176 DOI: 10.1073/pnas.1322466111] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
61 Jabbour EJ, Faderl S, Kantarjian HM. Adult Acute Lymphoblastic Leukemia. Mayo Clinic Proceedings 2005;80:1517-27. [DOI: 10.4065/80.11.1517] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
62 Rogers A, Graves M, Toscano M, Davis L. A unique cutaneous presentation of Burkitt lymphoma. Am J Dermatopathol 2014;36:997-1001. [PMID: 24562050 DOI: 10.1097/DAD.0000000000000004] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
63 Chatterjee T, Gupta D, Bharadwaj R, Madan R. Burkittts lymphoma revisited: series of three cases with varied clinical presentation. Indian J Hematol Blood Transfus 2014;30:215-8. [PMID: 25332582 DOI: 10.1007/s12288-014-0334-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Silva Junior WFD, Rosa LID, Belesso M, Lage LAPC, Rocha V, Pereira J. Treatment outcomes of adult Burkitt lymphoma: results with a modified LMB protocol in Brazil and feasibility of outpatient administration. Journal of Chemotherapy 2018;30:375-9. [DOI: 10.1080/1120009x.2018.1535771] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Tanaka YO, Okada S, Satoh T, Matsumoto K, Saida T, Oki A, Yoshikawa H, Minami M. Solid non-invasive ovarian masses on MR: Histopathology and a diagnostic approach. European Journal of Radiology 2011;80:e91-7. [DOI: 10.1016/j.ejrad.2010.05.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
66 Thomas X. Emerging drugs for adult acute lymphoblastic leukaemia. Expert Opin Emerg Drugs. 2005;10:591-617. [PMID: 16083331 DOI: 10.1517/14728214.10.3.591] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
67 Schmiester M, Tranter E, Lorusso A, Blaschke F, Geisel D, Bullinger L, Damm F, Na IK. Acute left ventricular insufficiency in a Burkitt Lymphoma patient with myocardial involvement and extensive local tumor cell lysis: a case report. BMC Cardiovasc Disord 2022;22:31. [PMID: 35120455 DOI: 10.1186/s12872-022-02480-5] [Reference Citation Analysis]
68 Palakodeti S, Hoda K, Munroe CA. Perirectal Burkitt lymphoma presenting as an uncommon cause of lower gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2014;12:A23-A24. [PMID: 24135467 DOI: 10.1016/j.cgh.2013.10.006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
69 Griskevicius L, Stulpinas R, Vengalyte I, Saulyte-trakymiene S, Mickys U, Pranys D, Kurtinaitis J, Jurgutis M. Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia. Leukemia Research 2009;33:587-8. [DOI: 10.1016/j.leukres.2008.07.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
70 Cogliatti SB, Novak U, Henz S, Schmid U, Moller P, Barth TFE. Diagnosis of Burkitt lymphoma in due time: a practical approach. Br J Haematol 2006;134:294-301. [DOI: 10.1111/j.1365-2141.2006.06194.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
71 Xuereb G, Borg J, Apap K, Borg C. The snoring 2-year-old boy: a case of primary nasopharyngeal Burkitt's lymphoma. BMJ Case Rep 2020;13:e233536. [PMID: 31980479 DOI: 10.1136/bcr-2019-233536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Issa DE, van de Schans SA, Chamuleau ME, Karim-Kos HE, Wondergem M, Huijgens PC, Coebergh JW, Zweegman S, Visser O. Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010. Haematologica 2015;100:525-33. [PMID: 25512643 DOI: 10.3324/haematol.2014.107300] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
73 Ribeiro de Almeida C, Stadhouders R, Thongjuea S, Soler E, Hendriks RW. DNA-binding factor CTCF and long-range gene interactions in V(D)J recombination and oncogene activation. Blood 2012;119:6209-18. [DOI: 10.1182/blood-2012-03-402586] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
74 Segot A, Raffoux E, Lengline E, Thieblemont C, Dombret H, Boissel N, Cluzeau T. Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma. Ann Hematol 2015;94:1859-63. [DOI: 10.1007/s00277-015-2475-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
75 Jakobsen LH, Ellin F, Smeland KB, Wästerlid T, Christensen JH, Jørgensen JM, Josefsson PL, Øvlisen AK, Holte H, Blaker YN, Grauslund JH, Bjørn J, Molin D, Lagerlöf I, Smedby KE, Colvin K, Thanarajasingam G, Maurer MJ, Habermann TM, Song KW, Zhu KY, Gerrie AS, Cheah CY, El-Galaly TC. Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients. Br J Haematol 2020;189:661-71. [PMID: 32017050 DOI: 10.1111/bjh.16425] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
76 Shachaf CM, Felsher DW. Rehabilitation of cancer through oncogene inactivation. Trends Mol Med 2005;11:316-21. [PMID: 15955741 DOI: 10.1016/j.molmed.2005.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
77 Patekar M, Gogia A, Tiwari A, Kumar L, Sharma A, Mallick SR, Sharma MC, Thulkar S, Gupta R. Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol. South Asian J Cancer 2018;7:195-9. [PMID: 30112340 DOI: 10.4103/sajc.sajc_230_17] [Reference Citation Analysis]
78 Sun Y, Orrenius S, Pervaiz S, Fadeel B. Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance. Blood 2005;105:4070-7. [DOI: 10.1182/blood-2004-10-4075] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
79 Song A, Ye J, Zhang K, Sun L, Zhao Y, Yu H. Lentiviral vector-mediated siRNA knockdown of c-MYC: cell growth inhibition and cell cycle arrest at G2/M phase in Jijoye cells. Biochem Genet 2013;51:603-17. [PMID: 23657834 DOI: 10.1007/s10528-013-9590-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
80 Connors JM. Non-Hodgkin lymphoma: the clinician's perspective--a view from the receiving end. Mod Pathol 2013;26 Suppl 1:S111-8. [PMID: 23281433 DOI: 10.1038/modpathol.2012.184] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
81 Guo J, Parise RA, Joseph E, Egorin MJ, Lazo JS, Prochownik EV, Eiseman JL. Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice. Cancer Chemother Pharmacol 2009;63:615-25. [PMID: 18509642 DOI: 10.1007/s00280-008-0774-y] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 5.7] [Reference Citation Analysis]
82 Corazzelli G, Frigeri F, Russo F, Frairia C, Arcamone M, Esposito G, De Chiara A, Morelli E, Capobianco G, Becchimanzi C, Volzone F, Saggese M, Marcacci G, De Filippi R, Vitolo U, Pinto A. RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B-cell lymphoma: RD-CODOX-M/IVAC in adult BL and BL/DLBCL. British Journal of Haematology 2012;156:234-44. [DOI: 10.1111/j.1365-2141.2011.08947.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
83 Sample JT, Ruf IK. Burkitt Lymphoma. In: Tselis A, Jenson HB, editors. Epstein-Barr Virus. Informa Healthcare; 2006. pp. 187-222. [DOI: 10.3109/9781420014280.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Montgomery ND, Fedoriw Y. Pathology Consultation on Intermediate-to-Large B-Cell Lymphomas. American Journal of Clinical Pathology 2014;141:305-17. [DOI: 10.1309/ajcp3cp6vfzjymtk] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
85 Lim HY, Thiel E, Glantz MJ. To protect and defend: central nervous system prophylaxis in patients with non-Hodgkinʼs lymphoma: . Current Opinion in Oncology 2008;20:495-501. [DOI: 10.1097/cco.0b013e32830b829e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
86 Mead GM, Barrans SL, Qian W, Walewski J, Radford JA, Wolf M, Clawson SM, Stenning SP, Yule CL, Jack AS; UK National Cancer Research Institute Lymphoma Clinical Studies Group., Australasian Leukaemia and Lymphoma Group. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood 2008;112:2248-60. [PMID: 18612102 DOI: 10.1182/blood-2008-03-145128] [Cited by in Crossref: 146] [Cited by in F6Publishing: 126] [Article Influence: 10.4] [Reference Citation Analysis]
87 Gkiafi Z, Panayotou G. Comparative Proteomic Analysis Implicates COMMD Proteins as Epstein–Barr Virus Targets in the BL41 Burkitt’s Lymphoma Cell Line. J Proteome Res 2011;10:2959-68. [DOI: 10.1021/pr100793m] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
88 Alfahadi MN, Malik FA, Almahlawi AS, Alhamdan WA. A rare case of the superior vena cava obstruction in a 16-year-old boy with Burkitt's lymphoma: A case report. J Taibah Univ Med Sci 2021;16:465-9. [PMID: 34140876 DOI: 10.1016/j.jtumed.2020.12.011] [Reference Citation Analysis]
89 Sagaert X, Tousseyn T, Yantiss RK. Gastrointestinal B-cell lymphomas: From understanding B-cell physiology to classification and molecular pathology. World J Gastrointest Oncol 2012; 4(12): 238-249 [PMID: 23443141 DOI: 10.4251/wjgo.v4.i12.238] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
90 Pinto A, Ikpatt OF, Chapman-Fredericks J. Burkitt lymphoma presenting as unilateral deafness in an immunocompetent patient. Case Rep Med 2012;2012:369264. [PMID: 23049564 DOI: 10.1155/2012/369264] [Reference Citation Analysis]
91 Choi MK, Jun HJ, Lee SY, Kim KH, Lim DH, Kim K, Ko YH, Kim WS, Kim SJ. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Ann Hematol 2009;88:1099-106. [DOI: 10.1007/s00277-009-0729-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
92 Yennam S, Kini AT, Al Othman B, Lee AG. Sixth nerve palsy in sporadic Burkitt Lymphoma. Am J Ophthalmol Case Rep 2019;16:100565. [PMID: 31737801 DOI: 10.1016/j.ajoc.2019.100565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
93 Cohen JB, Blum KA. Evaluation and management of lymphoma and leukemia in pregnancy. Clin Obstet Gynecol. 2011;54:556-566. [PMID: 22031246 DOI: 10.1097/GRF.0b013e318236e68a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
94 Chen ZY, Wu B, Yin JL. Intensive chemotherapy failure in Burkitt's lymphoma with cavernous sinus involvement. Med Oncol 2010;27:327-31. [PMID: 19365738 DOI: 10.1007/s12032-009-9213-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Kung BT, Mak WS, Lau SM, Auyong TK, Tong CM. Promising Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Human Immunodeficiency Virus Associated Non-Hodgkin's Lymphoma. World J Nucl Med 2015;14:53-6. [PMID: 25709547 DOI: 10.4103/1450-1147.150551] [Reference Citation Analysis]
96 Wen KW, Wang L, Menke JR, Damania B. Cancers associated with human gammaherpesviruses. FEBS J 2021. [PMID: 34536980 DOI: 10.1111/febs.16206] [Reference Citation Analysis]
97 Alves de Almeida M, Nesi Cardoso Migliano Porto J, de Brito Lyra AC, Calheiros Leite LA, Basilio-de-Oliveira RP, Neves-Motta R, Correa AR, Raphael de Almeida Ferry F, Eyer-Silva Wde A, Grechi Pacheco R. First Report of AIDS-Related Burkitt's Lymphoma Presenting as Bilateral Orbital Masses. Case Rep Infect Dis 2016;2016:6469528. [PMID: 27818811 DOI: 10.1155/2016/6469528] [Reference Citation Analysis]
98 Coakley D. Denis Burkitt and his contribution to haematology/oncology. Br J Haematol 2006;135:17-25. [DOI: 10.1111/j.1365-2141.2006.06267.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
99 Reyes-Garau D, Ribeiro ML, Roué G. Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications. Cancers (Basel) 2019;11:E1483. [PMID: 31581671 DOI: 10.3390/cancers11101483] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
100 Gandhi MK. Epstein-Barr virus-associated lymphomas. Expert Rev Anti Infect Ther 2006;4:77-89. [PMID: 16441211 DOI: 10.1586/14787210.4.1.77] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
101 Smith DP, Bath ML, Metcalf D, Harris AW, Cory S. MYC levels govern hematopoietic tumor type and latency in transgenic mice. Blood 2006;108:653-61. [PMID: 16537801 DOI: 10.1182/blood-2006-01-0172] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
102 Meister A, Hentrich M, Wyen C, Hübel K. Malignant lymphoma in the HIV-positive patient. Eur J Haematol 2018;101:119-26. [PMID: 29663523 DOI: 10.1111/ejh.13082] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
103 Lu SC, Shen WL, Cheng YM, Chou CY, Kuo PL. Burkitt'S lymphoma mimicking a primary gynecologic tumor. Taiwan J Obstet Gynecol 2006;45:162-6. [PMID: 17197360 DOI: 10.1016/S1028-4559(09)60217-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
104 Ng JY, Thompson RJ, Lam A, Nigam S. Sporadic Burkitt's lymphoma masquerading as an intussuscepted Meckel's diverticulum in a 9-year-old child. BMJ Case Rep 2018;2018:bcr-2018-224333. [PMID: 30042102 DOI: 10.1136/bcr-2018-224333] [Reference Citation Analysis]
105 Mawson AR, Majumdar S. Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma. Int J Cancer 2017;141:1849-55. [PMID: 28707393 DOI: 10.1002/ijc.30885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
106 Guan H, Xie L, Klapproth K, Weitzer CD, Wirth T, Ushmorov A. Decitabine represses translocated MYC oncogene in Burkitt lymphoma. J Pathol 2013;229:775-83. [PMID: 23341364 DOI: 10.1002/path.4164] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
107 Chan O, Igwe M, Breburda CS, Amar S. Burkitt Lymphoma Presenting as an Intracardiac Mass: Case Report and Review of Literature. Am J Case Rep 2016;17:553-8. [PMID: 27484990 DOI: 10.12659/ajcr.899022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
108 Harris AC, MacLean KA, Grunau GL, Chang SD, Martin N. Imaging Intra-abdominal Burkitt's Lymphoma: From Discrete Bowel Wall Thickening to Diffuse Soft Tissue Infiltration. Can Assoc Radiol J 2017;68:286-92. [PMID: 28578810 DOI: 10.1016/j.carj.2016.08.007] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 De Bonis P, Cingolani A, Pompucci A, Tartaglione T, Larocca LM, Teofili L. Cauda Equina Enhancing Lesion in an HIV-Infected Patient. Case Report and Literature Review. Mediterr J Hematol Infect Dis 2011;3:e2011042. [PMID: 22084656 DOI: 10.4084/MJHID.2011.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Taylor JS, Frey MK, Fatemi D, Robinson S. Burkitt's lymphoma presenting as ovarian torsion. American Journal of Obstetrics and Gynecology 2012;207:e4-6. [DOI: 10.1016/j.ajog.2012.05.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
111 Haralambieva E, Boerma E, van Imhoff GW, Rosati S, Schuuring E, Müller-hermelink HK, Kluin PM, Ott G. Clinical, Immunophenotypic, and Genetic Analysis of Adult Lymphomas With Morphologic Features of Burkitt Lymphoma. American Journal of Surgical Pathology 2005;29:1086-94. [DOI: 10.1097/01.pas.0000168176.71405.e5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
112 Jiang M, Zhu J, Guan YS, Zou LQ. Primary central nervous system burkitt lymphoma with non-immunoglobulin heavy chain translocation in right ventricle: case report. Pediatr Hematol Oncol 2011;28:454-8. [PMID: 21615246 DOI: 10.3109/08880018.2011.566599] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
113 Valnet-Rabier MB, Challier B, Thiebault S, Angonin R, Margueritte G, Mougin C, Kantelip B, Deconinck E, Cahn JY, Fest T. c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome. Br J Haematol 2005;128:767-73. [PMID: 15755279 DOI: 10.1111/j.1365-2141.2005.05378.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
114 Magrath I. Lessons from clinical trials in African Burkitt lymphoma: . Current Opinion in Oncology 2009;21:462-8. [DOI: 10.1097/cco.0b013e32832f3dcd] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
115 Turro J, Singh P, Sarao MS, Tadepalli S, Cheriyath P. Adult Burkitt lymphoma- an Island between lymphomas and leukemias. J Community Hosp Intern Med Perspect 2019;9:25-8. [PMID: 30788071 DOI: 10.1080/20009666.2019.1574545] [Reference Citation Analysis]
116 Li L, Gupta S, Bashir T, Koduru PR, Brody J, Allen SL. Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphoma. Cancer Genet Cytogenet 2006;170:140-6. [PMID: 17011985 DOI: 10.1016/j.cancergencyto.2006.05.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
117 Kenkre VP, Stock W. Burkitt lymphoma/leukemia: improving prognosis. Clin Lymphoma Myeloma 2009;9 Suppl 3:S231-8. [PMID: 19778846 DOI: 10.3816/CLM.2009.s.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
118 Campanero MR. Mechanisms involved in Burkitt's tumor formation. Clin Transl Oncol 2008;10:250-5. [PMID: 18490240 DOI: 10.1007/s12094-008-0193-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
119 Virdis P, Migheli R, Galleri G, Fancello S, Cadoni MPL, Pintore G, Petretto GL, Marchesi I, Fiorentino FP, di Francesco A, Sanges F, Bagella L, Muroni MR, Fozza C, De Miglio MR, Podda L. Antiproliferative and proapoptotic effects of Inula viscosa extract on Burkitt lymphoma cell line. Tumour Biol 2020;42:1010428319901061. [PMID: 32013807 DOI: 10.1177/1010428319901061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
120 Dozzo M, Carobolante F, Donisi PM, Scattolin A, Maino E, Sancetta R, Viero P, Bassan R. Burkitt lymphoma in adolescents and young adults: management challenges. Adolesc Health Med Ther 2017;8:11-29. [PMID: 28096698 DOI: 10.2147/AHMT.S94170] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
121 Wever CM, Geoffrion D, Grande BM, Yu S, Alcaide M, Lemaire M, Riazalhosseini Y, Hébert J, Gavino C, Vinh DC, Petrogiannis-Haliotis T, Dmitrienko S, Mann KK, Morin RD, Johnson NA. The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples. Leuk Lymphoma 2018;59:2159-74. [PMID: 29295643 DOI: 10.1080/10428194.2017.1413186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
122 Sharma P, Balasingham S, Stawiarski K, Rahmani M, Costantino A, Sharma P, Xu M, Masoud A. Burkitt lymphoma as a lead point for jejunojejunal intussusception in a human immunodeficiency virus patient. Clin J Gastroenterol 2017;10:342-50. [PMID: 28523628 DOI: 10.1007/s12328-017-0747-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
123 Maruyama D, Watanabe T, Maeshima AM, Nomoto J, Taniguchi H, Azuma T, Mori M, Munakata W, Kim SW, Kobayashi Y, Matsuno Y, Tobinai K. Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL. Int J Hematol 2010;92:732-43. [PMID: 21120644 DOI: 10.1007/s12185-010-0728-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
124 Feinberg SM, Ou SI, Gu M, Shibuya TY. Burkitt's Lymphoma of the Base of the Tongue: A Case Report and Review of the Literature. Ear Nose Throat J 2007;86:356-60. [DOI: 10.1177/014556130708600617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
125 Kalisz K, Alessandrino F, Beck R, Smith D, Kikano E, Ramaiya NH, Tirumani SH. An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence. Insights Imaging 2019;10:56. [PMID: 31115699 DOI: 10.1186/s13244-019-0733-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
126 de Leval L, Hasserjian RP. Diffuse Large B-Cell Lymphomas and Burkitt Lymphoma. Hematology/Oncology Clinics of North America 2009;23:791-827. [DOI: 10.1016/j.hoc.2009.04.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
127 Zayac AS, Olszewski AJ. Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy. Leuk Lymphoma 2020;61:1784-96. [PMID: 32255708 DOI: 10.1080/10428194.2020.1747068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
128 Lin Y, Pan YH, Li MK, Zong XD, Pan XM, Tan SY, Guo YW. Clinical presentation of gastric Burkitt lymphoma presenting with paraplegia and acute pancreatitis: A case report. World J Gastroenterol 2021; 27(45): 7844-7854 [PMID: 34963746 DOI: 10.3748/wjg.v27.i45.7844] [Reference Citation Analysis]
129 Siegal T, Goldschmidt N. CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom? Blood Reviews 2012;26:97-106. [DOI: 10.1016/j.blre.2011.12.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
130 Oosten LEM, Chamuleau MED, Thielen FW, de Wreede LC, Siemes C, Doorduijn JK, Smeekes OS, Kersten MJ, Hardi L, Baars JW, Demandt AMP, Stevens WBC, Nijland M, van Imhoff GW, Brouwer R, Uyl-de Groot CA, Kluin PM, de Jong D, Veelken H. Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens. Ann Hematol 2018;97:255-66. [PMID: 29209924 DOI: 10.1007/s00277-017-3167-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
131 de Jong D. Novel lymphoid neoplasms--the borderland between diffuse large B-cell lymphoma and Burkitt's lymphoma. Haematologica 2009;94:894-6. [PMID: 19570750 DOI: 10.3324/haematol.2009.008128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
132 Ejaz K, Khan QA, Raza MA, Ahmed RS, Aleem A. High-grade Burkitt Lymphoma Presenting as a Buttock Mass and Foot Drop. Cureus 2018;10:e3368. [PMID: 30510878 DOI: 10.7759/cureus.3368] [Reference Citation Analysis]
133 Fang X, Zhou X, Wang X. Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma. Biomark Res 2013;1:30. [PMID: 24252186 DOI: 10.1186/2050-7771-1-30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
134 Wästerlid T, Brown PN, Hagberg O, Hagberg H, Pedersen LM, D'Amore F, Jerkeman M. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Ann Oncol 2013;24:1879-86. [PMID: 23446093 DOI: 10.1093/annonc/mdt058] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
135 Noy A. Controversies in the treatment of Burkitt lymphoma in AIDS. Curr Opin Oncol 2010;22:443-8. [PMID: 20683266 DOI: 10.1097/CCO.0b013e32833d7dbe] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
136 Bueno MJ, Gómez de Cedrón M, Gómez-López G, Pérez de Castro I, Di Lisio L, Montes-Moreno S, Martínez N, Guerrero M, Sánchez-Martínez R, Santos J, Pisano DG, Piris MA, Fernández-Piqueras J, Malumbres M. Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway. Blood 2011;117:6255-66. [PMID: 21478429 DOI: 10.1182/blood-2010-10-315432] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
137 Lee S, Syed N, Taylor J, Smith P, Griffin B, Baens M, Bai M, Bourantas K, Stebbing J, Naresh K, Nelson M, Tuthill M, Bower M, Hatzimichael E, Crook T. DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma. Br J Cancer 2010;103:265-74. [PMID: 20551953 DOI: 10.1038/sj.bjc.6605711] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
138 Ankrah AO, Glaudemans AWJM, Klein HC, Dierckx RAJO, Sathekge M. The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases. Nucl Med Mol Imaging 2017;51:127-39. [PMID: 28559937 DOI: 10.1007/s13139-016-0422-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
139 Ghanim MT, Berman B. Immune Hemolytic Anemia (Paroxysmal Cold Hemoglobinuria) Preceding Burkitt Lymphoma in a 12-Year-Old Child. J Pediatr Hematol Oncol 2017;39:e25-6. [PMID: 27879544 DOI: 10.1097/MPH.0000000000000714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Arora A, Chiao E, Tyring SK. AIDS malignancies. Cancer Treat Res 2007;133:21-67. [PMID: 17672037 DOI: 10.1007/978-0-387-46816-7_2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
141 Johnson DH, Reske T, Ruiz M. Case report and review of immunodeficiency-associated Burkitt lymphoma. Clin Lymphoma Myeloma Leuk 2015;15:e121-5. [PMID: 25701328 DOI: 10.1016/j.clml.2014.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
142 Musekwa E, Chapanduka ZC, Bassa F, Kruger M. An 8-year retrospective study of adult and paediatric Burkitt’s lymphoma at Tygerberg Hospital, South Africa. South African Journal of Oncology 2020;4. [DOI: 10.4102/sajo.v4i0.93] [Reference Citation Analysis]
143 Cohen JB, Flowers CR. Optimal disease surveillance strategies in non-Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2014;2014:481-7. [PMID: 25696898 DOI: 10.1182/asheducation-2014.1.481] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
144 Hwang I, Go H, Jeon YK, Ko YH, Yoon DH, Suh C, Huh JR, Lee H, Gil M, Park CS. Expression of JL1 in Burkitt lymphoma is associated with improved overall survival. Virchows Arch 2011;459:353-9. [PMID: 21814778 DOI: 10.1007/s00428-011-1134-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
145 Lap CJ, Nassereddine S, Dunleavy K. Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma. Curr Treat Options Oncol 2021;22:60. [PMID: 34097157 DOI: 10.1007/s11864-021-00857-w] [Reference Citation Analysis]
146 Bhosale PR, Patnana M, Viswanathan C, Szklaruk J. The inguinal canal: anatomy and imaging features of common and uncommon masses. Radiographics. 2008;28:819-35; quiz 913. [PMID: 18480486 DOI: 10.1148/rg.283075110] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
147 Bustamante-Bernal M, Galvis J, Matos D, Sosa O, Syed SH, Padilla O, Davis B, Zuckerman MJ. Burkitt's Lymphoma of the Rectosigmoid and Stomach Presenting as Hematochezia. Am J Case Rep 2016;17:89-92. [PMID: 26876112 DOI: 10.12659/ajcr.896070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
148 Kasparian S, Burns E, Shehabeldin A, Awar M, Pingali SR. Recurrent small bowel obstruction caused by Burkitt lymphoma in an elderly man: a case report and review of the literature. J Med Case Rep 2020;14:127. [PMID: 32782017 DOI: 10.1186/s13256-020-02449-y] [Reference Citation Analysis]
149 Bacolla A, Wojciechowska M, Kosmider B, Larson JE, Wells RD. Gross Rearrangements Caused by Long Triplet and Other Repeat Sequences. Genetic Instabilities and Neurological Diseases. Elsevier; 2006. pp. 717-33. [DOI: 10.1016/b978-012369462-1/50047-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
150 Pinkerton R. Continuing challenges in childhood non-Hodgkin's lymphoma. Br J Haematol 2005;130:480-8. [PMID: 16098061 DOI: 10.1111/j.1365-2141.2005.05598.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
151 Lu R. Primary burkitt lymphoma of the chest wall. Case Rep Hematol 2012;2012:746098. [PMID: 22928128 DOI: 10.1155/2012/746098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
152 Ferry JA. Burkitt’s lymphoma: clinicopathologic features and differential diagnosis. Oncologist. 2006;11:375-383. [PMID: 16614233 DOI: 10.1634/theoncologist.11-4-375] [Cited by in Crossref: 200] [Cited by in F6Publishing: 161] [Article Influence: 12.5] [Reference Citation Analysis]
153 Okebe JU, Skoetz N, Meremikwu MM, Richards S. Therapeutic interventions for Burkitt lymphoma in children. Cochrane Database Syst Rev 2011;:CD005198. [PMID: 21735399 DOI: 10.1002/14651858.CD005198.pub3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
154 Upile T, Jerjes W, Abiola J, Kafas P, Sandison A, Hamdoon Z, Al-Khawalde M, Radhi H. A patient with primary Burkitt's lymphoma of the postnasal space: case report. Head Neck Oncol 2012;4:33. [PMID: 22695293 DOI: 10.1186/1758-3284-4-33] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
155 Carrillo-Cruz E, Marín-Oyaga VA, Solé Rodríguez M, Borrego-Dorado I, de la Cruz Vicente F, Quiroga Cantero E, Manzanares Pérez M, Capote FJ, Ramírez Sánchez MJ, Espigado Tocino I, Pérez-Vega H, Vázquez-Albertino R, Pérez-Simón JA. Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma. Eur J Haematol 2015;94:23-30. [PMID: 24520874 DOI: 10.1111/ejh.12284] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
156 Gandhi MK, Khanna R. Viruses and lymphoma. Pathology 2005;37:420-33. [DOI: 10.1080/003130200500368303] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
157 González-Barca E, Canales M, Salar A, Ferreiro-Martínez JJ, Ferrer-Bordes S, García-Marco JA, Sánchez-Blanco JJ, García-Frade J, Peñalver J, Bello-López JL, Sancho JM, Caballero D; GELTAMO group. Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial. Ann Hematol 2016;95:893-9. [PMID: 27025508 DOI: 10.1007/s00277-016-2648-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
158 Jackson SM, Wilson PC, James JA, Capra JD. Human B cell subsets. Adv Immunol 2008;98:151-224. [PMID: 18772006 DOI: 10.1016/S0065-2776(08)00405-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
159 Dickson BC, Serra S, Chetty R. Primary gastrointestinal tract lymphoma: diagnosis and management of common neoplasms. Expert Rev Anticancer Ther. 2006;6:1609-1628. [PMID: 17134365 DOI: 10.1586/14737140.6.11.1609] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
160 Kujawski LA, Longo WL, Williams EC, Turman NJ, Brandt N, Mosher DF, Eickhoff JC, Kahl BS. A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas. Cancer Investigation 2009;25:87-93. [DOI: 10.1080/07357900701205507] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
161 Balasubramaniam R, Goradia A, Turner LN, Stoopler ET, Alawi F, Frank DM, Greenberg MS. Burkitt lymphoma of the oral cavity: an atypical presentation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:240-245. [PMID: 19138642 DOI: 10.1016/j.tripleo.2008.09.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
162 Zhang H. Targeting autophagy in lymphomas: a double-edged sword? Int J Hematol 2018;107:502-12. [DOI: 10.1007/s12185-018-2414-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
163 Pannone G, Zamparese R, Pace M, Pedicillo MC, Cagiano S, Somma P, Errico ME, Donofrio V, Franco R, De Chiara A, Aquino G, Bucci P, Bucci E, Santoro A, Bufo P. The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based survey. Infect Agent Cancer 2014;9:34. [PMID: 25364378 DOI: 10.1186/1750-9378-9-34] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
164 Lim SH, Lee JY, Lee JY, Kim JH, Choi KH, Hyun JY, Ko YH, Lee J, Kim SJ, Kim WS. Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphoma. Jpn J Clin Oncol 2013;43:676-80. [PMID: 23564674 DOI: 10.1093/jjco/hyt047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
165 Abramson SJ, Price AP. Imaging of pediatric lymphomas. Radiol Clin North Am. 2008;46:313-318, ix. [PMID: 18619383 DOI: 10.1016/j.rcl.2008.03.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
166 Sakaguchi K, Imamura T, Ishimaru S, Imai C, Shimonodan H, Fujita N, Okada K, Taketani T, Kanai R, Tauchi H, Kato M, Kojima Y, Watanabe A, Deguchi T, Hashii Y, Kiyokawa N, Taki T, Saito AM, Horibe K, Manabe A, Sato A, Koh K. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan. Pediatr Blood Cancer 2020;67:e28341. [PMID: 32323914 DOI: 10.1002/pbc.28341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Tomska K, Kurilov R, Lee KS, Hüllein J, Lukas M, Sellner L, Walther T, Wagner L, Oleś M, Brors B, Huber W, Zenz T. Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma. Sci Rep 2018;8:12046. [PMID: 30104685 DOI: 10.1038/s41598-018-30509-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
168 Nomura Y, Yoshida S, Karube K, Takeshita M, Hirose S, Nakamura S, Yoshino T, Kikuchi M, Ohshima K. Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma. Cancer Science 2008;99:1564-9. [DOI: 10.1111/j.1349-7006.2008.00851.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
169 Pienkowska-Grela B, Rymkiewicz G, Grygalewicz B, Woroniecka R, Krawczyk P, Czyz-Domanska K, Walewski J. Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement. Med Oncol 2011;28:1589-95. [PMID: 20661666 DOI: 10.1007/s12032-010-9614-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
170 Saleh K, Michot JM, Camara-Clayette V, Vassetsky Y, Ribrag V. Burkitt and Burkitt-Like Lymphomas: a Systematic Review. Curr Oncol Rep 2020;22:33. [PMID: 32144513 DOI: 10.1007/s11912-020-0898-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
171 Fernandes C, Pinho R, Ribeiro I, Silva J, Ponte A, Leite S, Fraga J. Recurrent cecocolic intussusception in a young woman. Gastroenterol Hepatol 2015;38:586-8. [PMID: 25499847 DOI: 10.1016/j.gastrohep.2014.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Kridel R, Dietrich P. Prevention of CNS relapse in diffuse large B-cell lymphoma. The Lancet Oncology 2011;12:1258-66. [DOI: 10.1016/s1470-2045(11)70140-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
173 Abedin SM, Boddy CS, Munshi HG. BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects. Onco Targets Ther 2016;9:5943-53. [PMID: 27729803 DOI: 10.2147/OTT.S100515] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 6.2] [Reference Citation Analysis]
174 Vofo BN, Ngankam GVF, Ngwasiri CA, Atem JA, Aminde LN. Acute blindness as a presenting sign of childhood endemic Burkitt's lymphoma in Cameroon: a case report. J Med Case Rep 2018;12:129. [PMID: 29764474 DOI: 10.1186/s13256-018-1682-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
175 Kamulegeya A, Muwazi L, Kasaganki A, Rwenyonyi C, Kuteesa A. Trends in Burkitt's lymphoma: a three-decade retrospective study from Uganda: Trends of Burkitt's lymphoma in Uganda. Oral Surgery 2010;3:129-36. [DOI: 10.1111/j.1752-248x.2010.01095.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
176 Blinder VS, Chadburn A, Furman RR, Mathew S, Leonard JP. Review: Improving Outcomes for Patients with Burkitt Lymphoma and HIV. AIDS Patient Care and STDs 2008;22:175-87. [DOI: 10.1089/apc.2007.0124] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
177 Mertz JA, Kobayashi R, Dudley JP. ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer. J Virol 2007;81:3503-13. [PMID: 17229714 DOI: 10.1128/JVI.02253-06] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
178 Chen Y, Gong Y. Cytopathology in the Diagnosis of Lymphoma. In: Nayar R, editor. Cytopathology in Oncology. Berlin: Springer Berlin Heidelberg; 2014. pp. 211-40. [DOI: 10.1007/978-3-642-38850-7_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
179 Rajah J, Cain SA, Mews P. Intraventricular pseudolymphoma a case review. J Clin Neurosci 2020;78:425-7. [PMID: 32417128 DOI: 10.1016/j.jocn.2020.04.082] [Reference Citation Analysis]
180 Cheung CW, Burton C, Smith P, Linch DC, Hoskin PJ, Ardeshna KM. Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. Br J Haematol 2005;131:193-200. [DOI: 10.1111/j.1365-2141.2005.05756.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
181 Tauro S, Cochrane L, Lauritzsen GF, Baker L, Delabie J, Roberts C, Mahendra P, Holte H. Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols. Am J Hematol 2010;85:261-3. [DOI: 10.1002/ajh.21648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
182 Frick M, Dörken B, Lenz G. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma. Best Practice & Research Clinical Haematology 2012;25:3-12. [DOI: 10.1016/j.beha.2012.01.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
183 Lee S, Huang H, Niu Y, Tommasino M, Lenoir G, Sylla BS. Dok1 expression and mutation in Burkitt’s lymphoma cell lines. Cancer Lett. 2007;245:44-50. [PMID: 16338067 DOI: 10.1016/j.canlet.2005.10.045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
184 Tan JKH, Tan AHS, Wang S, Pang NQ. Intestinal obstruction in a virgin abdomen: a surgical trompe l'œil. ANZ J Surg 2021;91:E161-2. [PMID: 32767811 DOI: 10.1111/ans.16215] [Reference Citation Analysis]
185 Fulda S. Cell death in hematological tumors. Apoptosis 2009;14:409-23. [DOI: 10.1007/s10495-008-0306-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
186 Sissolak G, Seftel M, Uldrick TS, Esterhuizen TM, Mohamed N, Kotze D. Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital. J Glob Oncol 2017;3:218-26. [PMID: 28717763 DOI: 10.1200/JGO.2015.002378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
187 Kian TC, Miriam T, Richard Q, Peng YS, Li LE, Ivy S, Hwan-cheong TL, Hua LH, Thye LS. Clinical characteristics, prognostic factors and outcomes of Burkitt lymphoma in adult Asians. Leukemia & Lymphoma 2009;49:824-7. [DOI: 10.1080/10428190701882948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
188 Vincent C, Truffinet V, Fiancette R, Petit B, Cogné N, Cogné M, Denizot Y. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2009;1793:418-26. [DOI: 10.1016/j.bbamcr.2008.10.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
189 Gerecitano J, Straus DJ. Treatment of Burkitt lymphoma in adults. Expert Review of Anticancer Therapy 2014;6:373-81. [DOI: 10.1586/14737140.6.3.373] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
190 Mellors PW, Binder M, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Kapoor P, Gonsalves WI, Hwa YL, Fonder A, Hobbs M, Kourelis T, Warsame R, Zeldenrust SR, Lust JA, Leung N, Go RS, Kyle RA, Vincent Rajkumar S, Kumar SK. Time to plateau as a predictor of survival in newly diagnosed multiple myeloma. Am J Hematol 2018;93:889-94. [DOI: 10.1002/ajh.25113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
191 Murphy MJ, Wilson A, Trumpp A. More than just proliferation: Myc function in stem cells. Trends Cell Biol 2005;15:128-37. [PMID: 15752976 DOI: 10.1016/j.tcb.2005.01.008] [Cited by in Crossref: 120] [Cited by in F6Publishing: 126] [Article Influence: 7.1] [Reference Citation Analysis]
192 Mitra S, Mehta A, Gupta SK, Sharma A, Louis AR, Sharma MK, Saxena U, Simson DK, Dewan A. Primary Gastric Burkitt's Lymphoma. Rare Tumors 2014;6:5300. [PMID: 25568743 DOI: 10.4081/rt.2014.5300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 Laurent C, Guérin M, Frenois FX, Thuries V, Jalabert L, Brousset P, Valmary-Degano S. Whole-slide imaging is a robust alternative to traditional fluorescent microscopy for fluorescence in situ hybridization imaging using break-apart DNA probes. Hum Pathol 2013;44:1544-55. [PMID: 23517924 DOI: 10.1016/j.humpath.2012.12.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
194 Maeda E, Akahane M, Kiryu S, Kato N, Yoshikawa T, Hayashi N, Aoki S, Minami M, Uozaki H, Fukayama M, Ohtomo K. Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Jpn J Radiol 2009;27:4-19. [PMID: 19373526 DOI: 10.1007/s11604-008-0291-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 7.1] [Reference Citation Analysis]
195 Hoxha FT, Hashani SI, Krasniqi AS, Kurshumliu FI, Komoni DS, Hasimja SM, Maxhuni M. Intussusceptions as acute abdomen caused by Burkitt lymphoma: a case report. Cases J 2009;2:9322. [PMID: 20062585 DOI: 10.1186/1757-1626-2-9322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
196 Negahban S, Ahmadi N, Oryan A, Khojasteh HN, Aledavood A, Soleimanpour H, Mohammadianpanah M, Oschlies I, Gesk S, Siebert R, Daneshbod K, Daneshbod Y. Primary bilateral Burkitt lymphoma of the lactating breast: a case report and review of the literature. Mol Diagn Ther 2010;14:243-50. [PMID: 20799767 DOI: 10.1007/BF03256380] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
197 Ono Y, Kazuma Y, Ochi Y, Matsuoka R, Imai Y, Ishikawa T. Two Cases of Neurolymphomatosis with Fatal Bilateral Vocal Cord Paralysis that were Diagnosed with 18F-fluorodeoxyglucose Positron Emission Tomography (FDG PET)/CT. Intern Med 2017;56:1193-8. [PMID: 28502935 DOI: 10.2169/internalmedicine.56.6998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
198 Costes V. Pathologie lymphoïde de la tête et du cou. Annales de Pathologie 2009;29:323-34. [DOI: 10.1016/j.annpat.2009.07.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
199 Steininger H, Gruden J, Müller H. Primary Burkitt's Lymphoma of the Ovary in Early Weeks of Pregnancy - A Case Report. Geburtshilfe Frauenheilkd 2012;72:949-52. [PMID: 25264375 DOI: 10.1055/s-0032-1327777] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
200 Jevremovic D, Viswanatha DS. Molecular diagnosis of hematopoietic and lymphoid neoplasms. Hematol Oncol Clin North Am 2009;23:903-33. [PMID: 19577174 DOI: 10.1016/j.hoc.2009.04.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
201 Villa D, Connors J, Shenkier T, Gascoyne R, Sehn L, Savage K. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Annals of Oncology 2010;21:1046-52. [DOI: 10.1093/annonc/mdp432] [Cited by in Crossref: 130] [Cited by in F6Publishing: 121] [Article Influence: 10.8] [Reference Citation Analysis]
202 Ali A, Kalla A. Multiple cranial nerve palsies in immunodeficiency subtype of Burkitt lymphoma. J Community Hosp Intern Med Perspect 2018;8:303-6. [PMID: 30357018 DOI: 10.1080/20009666.2018.1514944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
203 Choudhary Z, Gupta P, Kumar MU. Burkitt's Lymphoma in HIV- Positive Child: Diagnostic Ascitic Fluid Cytology. J Clin Diagn Res 2017;11:EL01-2. [PMID: 28273979 DOI: 10.7860/JCDR/2017/24425.9137] [Reference Citation Analysis]
204 Bartlett NL. Lymphomas Presenting in the Head and Neck. Cummings Otolaryngology - Head and Neck Surgery. Elsevier; 2010. pp. 1673-81. [DOI: 10.1016/b978-0-323-05283-2.00120-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
205 Thomas DA, O'Brien S, Faderl S, Manning JT Jr, Romaguera J, Fayad L, Hagemeister F, Medeiros J, Cortes J, Kantarjian H. Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases? Curr Hematol Malig Rep 2011;6:58-66. [PMID: 21191675 DOI: 10.1007/s11899-010-0076-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
206 Havelange V, Ameye G, Théate I, Callet-bauchu E, Mugneret F, Michaux L, Dastugue N, Penther D, Barin C, Collonge-rame M, Baranger L, Terré C, Nadal N, Lippert E, Laï J, Cabrol C, Tigaud I, Herens C, Hagemeijer A, Raphael M, Libouton J, Poirel HA; On behalf of the GFCH (Groupe Francophone de Cytogénétique Hématologique). Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement. Genes Chromosom Cancer 2013;52:81-92. [DOI: 10.1002/gcc.22008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
207 Etonyeaku AC, Akinsanya OO, Ariyibi O, Aiyeyemi AJ. Chylothorax from Bilateral Primary Burkitt's Lymphoma of the Ovaries: A Case Report. Case Rep Obstet Gynecol 2012;2012:635121. [PMID: 22852103 DOI: 10.1155/2012/635121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
208 Ayoub F, Forde JJ, Patel N, Markham M. Primary gastric Burkitt lymphoma: a rare cause of life-threatening haematemesis. BMJ Case Rep 2017;2017:bcr-2017-220313. [PMID: 28830898 DOI: 10.1136/bcr-2017-220313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
209 Lewis RB, Mehrotra AK, Rodríguez P, Manning MA, Levine MS. From the radiologic pathology archives: gastrointestinal lymphoma: radiologic and pathologic findings. Radiographics 2014;34:1934-53. [PMID: 25384294 DOI: 10.1148/rg.347140148] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
210 Fei N, Shah N. Adult Sporadic Burkitt's Lymphoma Presenting with Rapid Development of Peritoneal Lymphomatosis. Case Rep Oncol Med 2017;2017:4789706. [PMID: 29130007 DOI: 10.1155/2017/4789706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
211 Sangma MM, Dasiah SD, Ashok AJ. Ileo-Colic Burkitt Lymphoma in a Young Adult Female- A Case Report. J Clin Diagn Res 2016;10:PD11-2. [PMID: 27190885 DOI: 10.7860/JCDR/2016/19105.7582] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
212 Mo YW, Xiao ZZ, Wei Y, Li XL, Zhang X, Fan W. The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma. Front Oncol 2021;11:625436. [PMID: 33968725 DOI: 10.3389/fonc.2021.625436] [Reference Citation Analysis]
213 Henrich S, Crossett B, Christopherson RI. Differentially expressed nuclear proteins in human CCRF-CEM, HL-60, MEC-1 and Raji cells correlate with cellular properties. Prot Clin Appl 2007;1:1252-65. [DOI: 10.1002/prca.200700055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
214 Oliveira C, Matos H, Serra P, Catarino R, Estevão A. Adult abdominal Burkitt lymphoma with isolated peritoneal involvement. J Radiol Case Rep 2014;8:27-33. [PMID: 24967011 DOI: 10.3941/jrcr.v8i1.1400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Alvarez W, Lai LH, Grant SJ, Sabath DE, Dillon J. Burkitt lymphoma of the maxilla in a HIV positive male - Presentation and review of diagnostic laboratory tests. Oral Maxillofac Surg Cases 2019;5:100113. [PMID: 33282691 DOI: 10.1016/j.omsc.2019.100113] [Reference Citation Analysis]
216 Wanschitz J, Dichtl W, Budka H, Löscher WN, Boesch S. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma. Muscle Nerve 2006;34:494-8. [DOI: 10.1002/mus.20569] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
217 Wästerlid T, Jonsson B, Hagberg H, Jerkeman M. Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study. Leukemia & Lymphoma 2011;52:2090-6. [DOI: 10.3109/10428194.2011.593274] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
218 In K, Zaini MA, Müller C, Warren AJ, von Lindern M, Calkhoven CF. Shwachman-Bodian-Diamond syndrome (SBDS) protein deficiency impairs translation re-initiation from C/EBPα and C/EBPβ mRNAs. Nucleic Acids Res 2016;44:4134-46. [PMID: 26762974 DOI: 10.1093/nar/gkw005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
219 Hutchison RE, Schexneider KI. Leukocytic Disorders. Henry's Clinical Diagnosis and Management by Laboratory Methods. Elsevier; 2011. pp. 601-55. [DOI: 10.1016/b978-1-4377-0974-2.00033-6] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
220 Gravos A, Sakellaridis K, Tselioti P, Katsifa K, Grammatikopoulou V, Nodarou A, Sarantos Κ, Tourtoglou A, Tsovolou E, Tsapas C, Prekates A. Burkitt lymphoma of the ovaries mimicking sepsis: a case report and review of the literature. J Med Case Rep 2018;12:285. [PMID: 30286805 DOI: 10.1186/s13256-018-1828-3] [Reference Citation Analysis]
221 Kudo Y, Tada H, Fujiwara N, Tada Y, Tsunematsu T, Miyake Y, Ishimaru N. Oral environment and cancer. Genes Environ 2016;38:13. [PMID: 27482300 DOI: 10.1186/s41021-016-0042-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
222 Blood JD, Khan A, Kamdar K, Foradori DM. Fever, Headache, and Sore Throat in a 7-year-old Girl. Pediatr Rev 2021;42:S89-92. [PMID: 33386372 DOI: 10.1542/pir.2019-0200] [Reference Citation Analysis]
223 Intermesoli T, Rambaldi A, Rossi G, Delaini F, Romani C, Pogliani EM, Pagani C, Angelucci E, Terruzzi E, Levis A, Cassibba V, Mattei D, Gianfaldoni G, Scattolin AM, Di Bona E, Oldani E, Parolini M, Gökbuget N, Bassan R. High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica 2013;98:1718-25. [PMID: 23753030 DOI: 10.3324/haematol.2013.086827] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
224 Bench AJ, Erber WN, Follows GA, Scott MA. Molecular genetic analysis of haematological malignancies II: mature lymphoid neoplasms. Int J Lab Haematol 2007;29:229-60. [DOI: 10.1111/j.1751-553x.2007.00876.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
225 Bellan C, Stefano L, Giulia de F, Rogena EA, Lorenzo L. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. Hematol Oncol. 2009;27:182-185. [PMID: 19670467 DOI: 10.1002/hon.914] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
226 Kalantri SA, Nayak A, Datta S, Bhattacharyya M. Isolated third nerve palsy: a rare neurological presentation of Burkitt's lymphoma. BMJ Case Rep 2017;2017:bcr-2017-219670. [PMID: 28765180 DOI: 10.1136/bcr-2017-219670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
227 Tonon G, Anderson KC. Lymphoma/Myeloma. The Molecular Basis of Cancer. Elsevier; 2008. pp. 351-9. [DOI: 10.1016/b978-141603703-3.10026-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
228 Komatsu N, Kawase-Koga Y, Mori Y, Kamikubo Y, Kurokawa M, Takato T. HIV-associated Burkitt lymphoma in a Japanese patient with early submandibular swelling. BMC Res Notes 2013;6:557. [PMID: 24370065 DOI: 10.1186/1756-0500-6-557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
229 Ross S, Eisenman K, Maloney KW. Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report. J Pediatr Hematol Oncol 2019;41:498-500. [PMID: 30095692 DOI: 10.1097/MPH.0000000000001287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
230 Chu Y, Nayyar G, Kham Su N, Rosenblum JM, Soon-Shiong P, Lee J, Safrit JT, Barth M, Lee D, Cairo MS. Novel cytokine-antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. J Immunother Cancer 2020;8:e001238. [PMID: 33109629 DOI: 10.1136/jitc-2020-001238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
231 Ingen-Housz-Oro S, Ortonne N, Hotz C, Moroch J, Le Bras F, Chosidow O, Haioun C. Cutaneous Tumor of the Arm Revealing a Sporadic Burkitt Lymphoma. J Am Geriatr Soc 2016;64:1141-2. [PMID: 27225370 DOI: 10.1111/jgs.14126] [Reference Citation Analysis]
232 Vincent-Fabert C, Fiancette R, Cogné M, Pinaud E, Denizot Y. The IgH 3' regulatory region and its implication in lymphomagenesis. Eur J Immunol 2010;40:3306-11. [PMID: 21080376 DOI: 10.1002/eji.201040778] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
233 Chopra M, Kraus S, Schwinn S, Ritz M, Mattenheimer K, Mottok A, Rosenwald A, Einsele H, Beilhack A. Non-invasive bioluminescence imaging to monitor the immunological control of a plasmablastic lymphoma-like B cell neoplasia after hematopoietic cell transplantation. PLoS One 2013;8:e81320. [PMID: 24349055 DOI: 10.1371/journal.pone.0081320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
234 Fuhrmann TL, Ignatovich YV, Pentland A. Cutaneous metastatic disease: Burkitt lymphoma. Journal of the American Academy of Dermatology 2011;64:1196-7. [DOI: 10.1016/j.jaad.2009.08.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
235 Yustein JT, Dang CV. Biology and treatment of Burkitt's lymphoma. Curr Opin Hematol 2007;14:375-81. [PMID: 17534164 DOI: 10.1097/MOH.0b013e3281bccdee] [Cited by in Crossref: 62] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
236 Dror T, Donovan V, Strubel N, Bhaumik S. Sporadic Burkitt Lymphoma Presenting with Middle Cranial Fossa Masses with Sphenoid Bony Invasion and Acute Pancreatitis in a Child. Case Rep Oncol Med 2021;2021:6610666. [PMID: 34567815 DOI: 10.1155/2021/6610666] [Reference Citation Analysis]
237 Hayashi T, Hirokawa M, Kuma S, Higuchi M, Suzuki A, Kanematsu R, Kudo T, Katsuki N, Haba R, Miyauchi A. Clinicopathological features of primary thyroid Burkitt's lymphoma: a systematic review and meta-analysis. Diagn Pathol 2020;15:13. [PMID: 32035483 DOI: 10.1186/s13000-020-00933-z] [Reference Citation Analysis]
238 Vincent-Fabert C, Fiancette R, Truffinet V, Cogné N, Cogné M, Denizot Y. Genetic background modulates susceptibility to oncogen-driven proliferation and lymphoma occurrence in mice carrying a deregulated c-myc transgene. Leuk Res 2009;33:e203-6. [PMID: 19524297 DOI: 10.1016/j.leukres.2009.05.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
239 Magrath I. Towards curative therapy in burkitt lymphoma: the role of early african studies in demonstrating the value of combination therapy and CNS prophylaxis. Adv Hematol 2012;2012:130680. [PMID: 22287968 DOI: 10.1155/2012/130680] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
240 Mattar WE, Alex BK, Sherker AH. Primary hepatic burkitt lymphoma presenting with acute liver failure. J Gastrointest Cancer 2010;41:261-3. [PMID: 20405241 DOI: 10.1007/s12029-010-9150-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
241 Zhang X, Suo S, Wang J, Jin J, Yu W. IDH1R132S -mutated acute lymphoblastic leukaemia resembles Burkitt lymphoma/leukaemia via activating MYC. Br J Haematol 2021;192:e44-7. [PMID: 33222166 DOI: 10.1111/bjh.17199] [Reference Citation Analysis]
242 Sengar M, Akhade A, Nair R, Menon H, Shet T, Gujral S, Sridhar E, Laskar S, Muckaden M. A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center. Indian J Med Paediatr Oncol 2011;32:197-203. [PMID: 22563152 DOI: 10.4103/0971-5851.95140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
243 Verdu-Bou M, Tapia G, Hernandez-Rodriguez A, Navarro JT. Clinical and Therapeutic Implications of Epstein-Barr Virus in HIV-Related Lymphomas. Cancers (Basel) 2021;13:5534. [PMID: 34771697 DOI: 10.3390/cancers13215534] [Reference Citation Analysis]
244 Matis S, Mariani MR, Cutrona G, Cilli M, Piccardi F, Daga A, Damonte G, Millo E, Moroni M, Roncella S, Fedeli F, Boffa LC, Ferrarini M. PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease. Cancer Gene Ther 2009;16:786-93. [PMID: 19363465 DOI: 10.1038/cgt.2009.26] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
245 Musallam KM, Taher AT, Shamseddine AI. Burkitt's lymphoma of the colon and bronchi: three case reports. Cases J 2008;1:15. [PMID: 18577260 DOI: 10.1186/1757-1626-1-15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
246 Choi KA, Lee JE, Kim Y, Kim DJ, Kim K, Ko YH, Oh HY, Kim WS, Huh W. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Ann Hematol 2009;88:639-45. [DOI: 10.1007/s00277-008-0642-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
247 Ma'koseh M, Amarin R, Tamimi F, Sharaf B, Abufara A, Shahin O, Manassra MKM, Halahleh K. Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan. Blood Res 2021;56:279-84. [PMID: 34880141 DOI: 10.5045/br.2021.2021116] [Reference Citation Analysis]
248 Magrath IT. Treatment of Burkitt lymphoma in children and adults: Lessons from Africa. Curr Hematol Malig Rep 2006;1:230-40. [PMID: 20425318 DOI: 10.1007/s11899-006-0004-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
249 Ayee R, Ofori MEO, Wright E, Quaye O. Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans. J Cancer 2020;11:1737-50. [PMID: 32194785 DOI: 10.7150/jca.37282] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
250 Jang S, Yoon DH, Kim S, Yoon S, Kim DY, Park C, Huh J, Lee S, Lee DH, Ryu J, Suh C. A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience. Ann Hematol 2012;91:1917-22. [DOI: 10.1007/s00277-012-1531-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
251 Silva WFD, Garibaldi PMM, Rosa LID, Bellesso M, Clé DV, Delamain MT, Rego EM, Pereira J, Rocha V. Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study. Leuk Res 2020;89:106287. [PMID: 31864677 DOI: 10.1016/j.leukres.2019.106287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
252 Lam MS. Treatment of Burkitt's lymphoma during pregnancy. Ann Pharmacother 2006;40:2048-52. [PMID: 17062832 DOI: 10.1345/aph.1H289] [Cited by in Crossref: 17] [Article Influence: 1.1] [Reference Citation Analysis]
253 Albano D, Bosio G, Pagani C, Re A, Tucci A, Giubbini R, Bertagna F. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma. Eur J Nucl Med Mol Imaging 2019;46:87-96. [PMID: 30276438 DOI: 10.1007/s00259-018-4173-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
254 Tang Y, Jiao X, Chang X, Huang D. Risk factors for the evaluation of potential central nervous system metastasis in Burkitt's lymphoma: a case study and literature review: Risk factors of CNS metastasis in BL. Hematol Oncol 2016;34:36-41. [DOI: 10.1002/hon.2159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
255 Slack GW, Hsi ED, Gascoyne RD. Diffuse Aggressive B-Cell Lymphomas. Hematopathology. Elsevier; 2012. pp. 261-92. [DOI: 10.1016/b978-1-4377-2606-0.00008-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
256 Kremer M, Quintanilla-Martínez L, Nährig J, von Schilling C, Fend F. Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis. Virchows Arch 2005;447:920-37. [PMID: 16231177 DOI: 10.1007/s00428-005-0070-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
257 Kalinyak JE, Kong CS, McDougall IR. Burkitt's lymphoma presenting as a rapidly growing thyroid mass. Thyroid 2006;16:1053-7. [PMID: 17042693 DOI: 10.1089/thy.2006.16.1053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
258 Coelho R, Gonçalves R, Costa J, Macedo G. Burkitt's Lymphoma Diagnosed by Colonoscopy in Immunocompetent Patient. GE Port J Gastroenterol 2015;22:130-1. [PMID: 28868393 DOI: 10.1016/j.jpge.2015.02.002] [Reference Citation Analysis]
259 Ramasubramanian A, Shields CL, Longmire M, Hunt DJ. Secondary choroidal lymphoma in a child treated for Burkitt lymphoma. J AAPOS 2011;15:94-5. [PMID: 21397815 DOI: 10.1016/j.jaapos.2010.12.004] [Reference Citation Analysis]
260 Graham JP, Arcipowski KM, Bishop GA. Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1. Immunol Rev 2010;237:226-48. [PMID: 20727039 DOI: 10.1111/j.1600-065X.2010.00932.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
261 Doherty B, Palmer W, Cvinar J, Sadek N. A Rare Case of Systemic Adult Burkitt Lymphoma Presenting as Acute Acalculous Cholecystitis.ACG Case Rep J. 2019;6:e00048. [PMID: 31616732 DOI: 10.14309/crj.0000000000000048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Ni Z, Dai X, Wang B, Ding W, Cheng P, Xu L, Lian J, He F. Natural Bcl-2 inhibitor (-)- gossypol induces protective autophagy via reactive oxygen species-high mobility group box 1 pathway in Burkitt lymphoma. Leuk Lymphoma 2013;54:2263-8. [PMID: 23398207 DOI: 10.3109/10428194.2013.775437] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
263 Al Sbihi A, Manasrah N, Sano D, Lonardo S. Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy. BMJ Case Rep 2021;14:e240925. [PMID: 33879463 DOI: 10.1136/bcr-2020-240925] [Reference Citation Analysis]
264 Ghazzaui N, Saintamand A, Issaoui H, Vincent-Fabert C, Denizot Y. The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis. Oncotarget 2017;8:7059-67. [PMID: 27729620 DOI: 10.18632/oncotarget.12535] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
265 Davidson T, Priel E, Schiby G, Raskin S, Chikman B, Nissan E, Benjamini O, Nissan J, Goshen E, Ben-Haim S, Salomon O, Avigdor A. Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT. Abdom Radiol (NY) 2018;43:2369-74. [PMID: 29460043 DOI: 10.1007/s00261-017-1454-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
266 Liu D, Shimonov J, Primanneni S, Lai Y, Ahmed T, Seiter K. t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia. Mol Cancer 2007;6:35. [PMID: 17547754 DOI: 10.1186/1476-4598-6-35] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
267 Khan A, Khan S, Arshad U. Primary Gastric Burkitt's lymphoma. Pak J Med Sci 2017;33:1294-7. [PMID: 29142583 DOI: 10.12669/pjms.335.13002] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
268 Maino E, Bonifacio M, Scattolin AM, Bassan R. Immunotherapy approaches to treat adult acute lymphoblastic leukemia. Expert Review of Hematology 2016;9:563-77. [DOI: 10.1586/17474086.2016.1170593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
269 Ge X, Du Y, Chen J, Zhu N, Yao J, Zhang X, Wang N, Sun Y, Gao F, Hu W, Hou Y. Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis. Front Oncol 2021;11:751904. [DOI: 10.3389/fonc.2021.751904] [Reference Citation Analysis]
270 Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM. AIDS-Related Burkitt's Lymphoma Versus Diffuse Large-Cell Lymphoma in the Pre–Highly Active Antiretroviral Therapy (HAART) and HAART Eras: Significant Differences in Survival With Standard Chemotherapy. JCO 2005;23:4430-8. [DOI: 10.1200/jco.2005.11.973] [Cited by in Crossref: 151] [Cited by in F6Publishing: 28] [Article Influence: 8.9] [Reference Citation Analysis]
271 Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol. 2007;60:1397-1402. [PMID: 18716017 DOI: 10.1136/jcp.2007.047977] [Cited by in Crossref: 58] [Cited by in F6Publishing: 95] [Article Influence: 3.9] [Reference Citation Analysis]
272 Richter-Larrea JA, Robles EF, Fresquet V, Beltran E, Rullan AJ, Agirre X, Calasanz MJ, Panizo C, Richter JA, Hernandez JM, Roman-Gomez J, Prosper F, Martinez-Climent JA. Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma. Blood 2010;116:2531-42. [PMID: 20570860 DOI: 10.1182/blood-2010-02-268003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
273 Casulo C, Friedberg JW. Burkitt lymphoma- a rare but challenging lymphoma. Best Pract Res Clin Haematol 2018;31:279-84. [PMID: 30213397 DOI: 10.1016/j.beha.2018.07.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
274 Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S, Wierda WG, Pierce SA. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569-1580. [PMID: 16502413 DOI: 10.1002/cncr.21776] [Cited by in Crossref: 362] [Cited by in F6Publishing: 297] [Article Influence: 22.6] [Reference Citation Analysis]
275 Canet E, Zafrani L, Lambert J, Thieblemont C, Galicier L, Schnell D, Raffoux E, Lengline E, Chevret S, Darmon M, Azoulay E. Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS One 2013;8:e55870. [PMID: 23457485 DOI: 10.1371/journal.pone.0055870] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
276 Pereira RF, Mauro GP, Medici CTM, Casimiro LC, Weltman E. Radiotherapy in Adult Burkitt Lymphoma: A Retrospective Analysis in a Large University Center. Indian J Hematol Blood Transfus. [DOI: 10.1007/s12288-021-01495-w] [Reference Citation Analysis]
277 Nagori SA, Jose A, Bhutia O, Roychoudhury A. Images in emergency medicine. Young male with rapidly swelling jaw. Burkitt's lymphoma of the jaws. Ann Emerg Med 2015;65:255-76. [PMID: 25702180 DOI: 10.1016/j.annemergmed.2014.05.022] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
278 Mimery AH, Jabbour J, Sykes B, MacDermid E, Al-Askari M, De Clercq S. Burkitt Leukemia Presenting as Acute Appendicitis: A Case Report and Literature Review. Am J Case Rep 2020;21:e921568. [PMID: 32094318 DOI: 10.12659/AJCR.921568] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
279 Muñoz Martín AJ, Pérez Fernández R, Viñuela Beneítez MC, Martínez Marín V, Marquéz-Rodas I, Sabin Domínguez P, García Alfonso P. Primary ovarian Burkitt lymphoma. Clin Transl Oncol 2008;10:673-5. [PMID: 18940750 DOI: 10.1007/s12094-008-0270-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
280 Gray A, Dang BN, Moore TB, Clemens R, Pressman P. A review of nutrition and dietary interventions in oncology. SAGE Open Med 2020;8:2050312120926877. [PMID: 32537159 DOI: 10.1177/2050312120926877] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
281 Dong LH, Cheng S, Zheng Z, Wang L, Shen Y, Shen ZX, Chen SJ, Zhao WL. Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/Lymphoma. J Hematol Oncol. 2013;6:53. [PMID: 23866964 DOI: 10.1186/1756-8722-6-53] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
282 Koca T, Aslan N, Dereci S, Akcam M. Burkitt lymphoma with unusual presentation: Acute pancreatitis. Pediatr Int 2015;57:775-7. [PMID: 26031558 DOI: 10.1111/ped.12640] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
283 Tam WL, Ang YS, Lim B. The molecular basis of ageing in stem cells. Mech Ageing Dev 2007;128:137-48. [PMID: 17134742 DOI: 10.1016/j.mad.2006.11.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
284 Qualls D, Abramson JS. Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma. Haematologica 2019;104:25-34. [PMID: 30573511 DOI: 10.3324/haematol.2018.195834] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
285 Davison JM, Subramaniam RM, Surasi DS, Cooley T, Mercier G, Peller PJ. FDG PET/CT in Patients With HIV. American Journal of Roentgenology 2011;197:284-94. [DOI: 10.2214/ajr.10.6332] [Cited by in Crossref: 36] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
286 Smyth L, Browne PV, Conneally E, Flynn C, Hayden P, Jeffers M, O'Brien D, Quinn F, Kelly J, Perera M, Crotty GM, Leahy M, Hennessy B, Jackson F, Ryan M, Vandenberghe E. Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL. Ir J Med Sci 2016;185:773-7. [PMID: 25843016 DOI: 10.1007/s11845-015-1288-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
287 Mazhar D, Stebbing J, Bower M. Non-Hodgkin’s lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals. Expert Review of Anticancer Therapy 2014;6:335-41. [DOI: 10.1586/14737140.6.3.335] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
288 Ravandi F, Faderl S, Kebriaei P, Kantarjian H. Modern treatment programs for adults with acute lymphoblastic leukemia. Curr Hematol Malig Rep 2007;2:169-75. [DOI: 10.1007/s11899-007-0023-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
289 Singavi AK, Harrington AM, Fenske TS. Post-transplant lymphoproliferative disorders. Cancer Treat Res. 2015;165:305-327. [PMID: 25655616 DOI: 10.1007/978-3-319-13150-4_13] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
290 Rodig SJ, Vergilio J, Shahsafaei A, Dorfman DM. Characteristic Expression Patterns of TCL1, CD38, and CD44 Identify Aggressive Lymphomas Harboring a MYC Translocation. American Journal of Surgical Pathology 2008;32:113-22. [DOI: 10.1097/pas.0b013e3180959e09] [Cited by in Crossref: 39] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
291 Sotiropoulou M, Stavrinou N, Vailas M, Alexakou P, Psarologos M, Metaxas P, Economou M, Vourlakou C, Kapiris S. An unusual cause of large bowel obstruction: are we aware of this? Pan Afr Med J 2020;36:223. [PMID: 33708314 DOI: 10.11604/pamj.2020.36.223.24718] [Reference Citation Analysis]
292 Bodrog A, Zhang B, Liu L, Casulo C, Bennett JM. A case of Burkitt Leukemia: Revisiting the prognostic value of lactate dehydrogenase. Leuk Res 2020;89:106295. [PMID: 31924584 DOI: 10.1016/j.leukres.2019.106295] [Reference Citation Analysis]
293 Tapia G, Lopez R, Muñoz-mármol AM, Mate JL, Sanz C, Marginet R, Navarro J, Ribera J, Ariza A. Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas: MYC immunohistochemistry in DLBCL and Burkitt lymphoma. Histopathology 2011;59:672-8. [DOI: 10.1111/j.1365-2559.2011.03978.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
294 Durán HJ, Díaz-Morfa M, García-Parreñoa J, Bellón JM. [Burkitt's lymphoma affecting only the thyroid]. Med Clin (Barc) 2008;131:38-9. [PMID: 18582427 DOI: 10.1157/13123047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
295 D'Achille P, Seymour JF, Campbell LJ. Translocation (14;18)(q32;q21) in acute lymphoblastic leukemia: a study of 12 cases and review of the literature. Cancer Genet Cytogenet 2006;171:52-6. [PMID: 17074591 DOI: 10.1016/j.cancergencyto.2006.07.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
296 Just P, Fieschi C, Baillet G, Galicier L, Oksenhendler E, Moretti J. 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in AIDS-Related Burkitt Lymphoma. AIDS Patient Care and STDs 2008;22:695-700. [DOI: 10.1089/apc.2008.0174] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
297 Wessels G, Bernard Hesseling P. Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa. Transfusion and Apheresis Science 2005;32:27-31. [DOI: 10.1016/j.transci.2004.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
298 Castillo G, Argyropoulos K, Moen FM, Bhakta D. Gastrointestinal Bleeding in a Patient With Gastric Lymphoma, Tuberculosis Enteritis, and Cytomegalovirus Enteritis. ACG Case Rep J 2020;7:e00317. [PMID: 32309509 DOI: 10.14309/crj.0000000000000317] [Reference Citation Analysis]
299 Parker SM, Olteanu H, VanTuinen P, Lawton CA, Schultz CJ, Christians KK, Fenske TS. Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy. Int J Hematol 2009;90:616-22. [PMID: 19937165 DOI: 10.1007/s12185-009-0444-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
300 Herrlinger U, Glantz M, Schlegel U, Gisselbrecht C, Cavalli F. Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out More. Seminars in Oncology 2009;36:S25-34. [DOI: 10.1053/j.seminoncol.2009.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
301 Galicier L, Fieschi C, Borie R, Meignin V, Daniel M, Gérard L, Oksenhendler E. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Blood 2007;110:2846-54. [DOI: 10.1182/blood-2006-10-051771] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
302 Quijano S, López A, Rasillo A, Barrena S, Luz Sánchez M, Flores J, Fernández C, Sayagués JM, Osuna CS, Fernández N, González M, Giraldo P, Giralt M, Pérez MC, Martin-antoran JM, Gutiérrez O, Perdiguer L, Díaz Mediavilla J, González Silva M, Asensio del Rio A, Cerveró C, Guerra JL, Butrón R, del Carmen García M, Almeida J, Orfao A. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients. Blood 2008;111:5130-41. [DOI: 10.1182/blood-2007-10-119289] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
303 Mcnamara Y, Bright S, Byrne A, Cloonan S, Mccabe T, Williams D, Meegan M. Synthesis and antiproliferative action of a novel series of maprotiline analogues. European Journal of Medicinal Chemistry 2014;71:333-53. [DOI: 10.1016/j.ejmech.2013.10.076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]